The British government has struck a deal for 60 million doses of coronavirus vaccine. Downing Street has signed a supply deal for a vaccine being developed by Sanofi and GlaxoSmithKline in its fourth such arrangement, it has announced today.
No vaccine has yet been approved to treat or prevent Covid-19, the respiratory disease caused by the coronavirus that has killed more than 659,000 people and unleashed economic havoc worldwide.
Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be won by the first half of 2021 if clinical data was positive.